These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9553673)

  • 1. 5-Fluorouracil and mitomycin-C in colorectal cancer: unacceptable conclusion.
    Herrmann R
    Ann Oncol; 1998 Feb; 9(2):230. PubMed ID: 9553673
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Fluorouracil and mitomycin-C in colorectal cancer: unacceptable conclusion.
    Herrmann R
    Ann Oncol; 1998 Mar; 9(3):342. PubMed ID: 9714583
    [No Abstract]   [Full Text] [Related]  

  • 3. Can mitomycin C represent a valid partner for 5-fluorouracil in second-line chemotherapy of colorectal cancer?
    Tassinari D; Arcangeli V; Panzini I; Sartori S; Gianni L; Ravaioli A
    Ann Oncol; 2000 Aug; 11(8):1071. PubMed ID: 11038049
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy for colorectal carcinoma.
    Daldiyono ; Ismail Ali A; Simadibrata R; Aziz Rani A; Chudahman M; Dharmika D
    Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1236-8. PubMed ID: 1514838
    [No Abstract]   [Full Text] [Related]  

  • 5. Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma.
    Kang EJ; Choi YJ; Kim JS; Kim ST; Park KH; Choi IK; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):286-91. PubMed ID: 21114778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second line treatment options in advanced colorectal cancer.
    Stewart JM; Millward MJ; Zalcberg JR
    Eur J Cancer; 1998 Jun; 34(7):953-5. PubMed ID: 9849438
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of combination chemotherapy to adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in patients with gastric or colorectal cancer].
    Kamoshita N; Yokomori T; Iesato H; Ohya T; Nagaoka H; Okabe T; Kato Y; Takeyoshi I; Ohwada S; Morishita Y
    Gan To Kagaku Ryoho; 2000 May; 27(5):711-6. PubMed ID: 10832439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination therapy including mutamycin (mitomycin C) in the treatment of advanced colorectal and gastric cancer].
    Manziuk LV; Artamonova EV; Sholokhov VN; Strygina EA
    Vopr Onkol; 2001; 47(6):736-9. PubMed ID: 11826500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man.
    Ota K; Kurita S; Nishimura M; Ogawa M; Kamei Y; Imai K; Ariyoshi Y; Kataoka K; Murakami M; Oyama A; Hoshino A; Amo H; Kato T
    Cancer Chemother Rep; 1972 Jun; 56(3):373-85. PubMed ID: 19051498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiblastic treatment in metastatic colorectal cancer].
    Mustacchi G; Milani S
    Ann Ital Chir; 1992; 63(3):333-6. PubMed ID: 1280019
    [No Abstract]   [Full Text] [Related]  

  • 11. Raltitrexed and mitomycin-C as third-line chemotherapy for colorectal cancer after combination regimens including 5-fluorouracil, irinotecan and oxaliplatin: a phase II study.
    Rosati G; Rossi A; Germano D; Reggiardo G; Manzione L
    Anticancer Res; 2003; 23(3C):2981-5. PubMed ID: 12926149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous 24-hour infusion of folinic acid does not increase the response rate of 5-fluorouracil but only the toxicity.
    Tsavaris N; Tzannou I; Karvounis N; Kosmidis P
    Oncology; 1992; 49(2):154-6. PubMed ID: 1574252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil (FU) and mitomycin C (MMC) in the management of colorectal carcinoma. Part II. In vitro activity of the two drugs in short-term tumor cultures.
    Franchi F; Barone C; Seminara P; Codacci-Pisanelli G; Codacci-Pisanelli M; Ferri GM; Garufi C; Grieco A; Pagani V
    Med Oncol Tumor Pharmacother; 1991; 8(2):75-8. PubMed ID: 1749303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Final evaluation of the randomized multicenter study SAKK 40/81: adjuvant portal chemotherapy of curatively resected colorectal cancer].
    Laffer U; Metzger U; Aeberhard P; Arigoni M; Arma S; Barras J; Egeli R; Martinoli S; Müller W; Schweizer W
    Helv Chir Acta; 1992 Mar; 58(5):755-8. PubMed ID: 1592650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil, high-dose folinic acid and mitomycin C combination chemotherapy in previously treated patients with advanced colorectal carcinoma.
    Seitz JF; Perrier H; Giovannini M; Capodano G; Bernardini D; Bardou VJ
    J Chemother; 1998 Jun; 10(3):258-65. PubMed ID: 9669654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternating 5-FU-mitomycin C/5-FU-dacarbazine in advanced colorectal adenocarcinoma: a phase II study.
    Herait P; Rougier P; Theodore C; Kac JL; Droz JP
    Oncology; 1989; 46(2):88-90. PubMed ID: 2496369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-fluorouracil and mitomycin-C: effective, low-cost chemotherapy for colorectal cancer.
    Aphinives P; Bhudhisawasdi V; Sae-seow O; Uttaravichien T
    J Med Assoc Thai; 2006 Nov; 89(11):1885-9. PubMed ID: 17205869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine and mitomycin-C in the therapy of pretreated patients with metastatic colorectal cancer: single center retrospective study with 36 patients.
    Vrdoljak E; Omrcen T; Boban M; Hrepic D
    J BUON; 2008; 13(4):513-8. PubMed ID: 19145672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.
    Shimizu T; Sonoda H; Murata S; Takebayashi K; Ohta H; Miyake T; Mekata E; Shiomi H; Naka S; Tani T
    Eur J Surg Oncol; 2014 May; 40(5):521-528. PubMed ID: 24388411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.